X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

HOOK

Closed

Hookipa Pharma Inc

1.25
-0.01 (-0.80%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.255
Day's Range: 1.2358 - 1.35
Send
When Written:
 
0.732
Hookipa Pharma Inc. is a biotechnology company that is focused on developing immunotherapies for infectious diseases and cancers. The company is headquartered in New York City, with research and development facilities in Austria. Hookipa's lead product candidate is HB-101, a therapeutic vaccine that targets human papillomavirus (HPV) positive cancers. The company is also developing other product candidates, including HB-201 and HB-202, which are designed to stimulate the immune system to fight cancer. Hookipa is backed by a number of venture capital firms, including Sofinnova Partners, Forbion Capital Partners, and Takeda Ventures. The company went public in 2019 and is listed on the NASDAQ under the ticker symbol "HOOK".

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X